coya 303
Generic: low-dose interleukin-2 and glucagon-like-peptide-1 receptor agonist·Code: COYA 303
coya 303: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Coya Therapeutics, Inc. (COYA) | Phase 2 |
Get deeper analysis on coya 303
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis